Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nanosonics Limited ( (AU:NAN) ) has issued an announcement.
Nanosonics Limited has provided an updated notification on its on-market share buy-back program, clarifying that a daily buy-back report dated 24 March 2026 was subject to an administrative oversight. The company has now trued up its buy-back records, confirming that a total of 4,589,010 shares had been repurchased prior to the latest reporting day, with an additional 118,331 shares bought back on the previous trading day.
The update, lodged on 15 April 2026, follows the initial buy-back notification made on 2 December 2025 and the most recent prior update on 13 April 2026. While the filing is largely procedural, it underscores ongoing capital management through an on-market buy-back of ordinary fully paid shares, a move that may support earnings per share and signal management’s confidence in the company’s valuation to investors.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is an Australia-listed medical technology company trading under the ASX code NAN. It is known for developing and supplying infection prevention solutions, with its primary securities being ordinary fully paid shares listed on the ASX.
Average Trading Volume: 782,547
Technical Sentiment Signal: Sell
Current Market Cap: A$1.13B
Learn more about NAN stock on TipRanks’ Stock Analysis page.